Business Description
Coya Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US22407B1089
Description
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.86 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 12.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.44 | |||||
| 9-Day RSI | 43.78 | |||||
| 14-Day RSI | 44.37 | |||||
| 6-1 Month Momentum % | 84.2 | |||||
| 12-1 Month Momentum % | 87.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.15 | |||||
| Quick Ratio | 8.15 | |||||
| Cash Ratio | 6.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -122.63 | |||||
| Net Margin % | -133.07 | |||||
| FCF Margin % | -186.42 | |||||
| ROE % | -59.84 | |||||
| ROA % | -42.74 | |||||
| ROIC % | -611.09 | |||||
| ROC (Joel Greenblatt) % | -7913.98 | |||||
| ROCE % | -45.84 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 15.37 | |||||
| PB Ratio | 3.4 | |||||
| Price-to-Tangible-Book | 3.4 | |||||
| EV-to-EBIT | -18.88 | |||||
| EV-to-EBITDA | -18.94 | |||||
| EV-to-Revenue | 23.15 | |||||
| EV-to-FCF | -12.39 | |||||
| Price-to-Net-Current-Asset-Value | 3.4 | |||||
| Price-to-Net-Cash | 4.49 | |||||
| Earnings Yield (Greenblatt) % | -5.3 | |||||
| FCF Yield % | -9.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:COYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coya Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6.002 | ||
| EPS (TTM) ($) | -0.78 | ||
| Beta | 0 | ||
| Volatility % | 74.77 | ||
| 14-Day RSI | 44.37 | ||
| 14-Day ATR ($) | 0.681574 | ||
| 20-Day SMA ($) | 8.9375 | ||
| 12-1 Month Momentum % | 87.91 | ||
| 52-Week Range ($) | 3.21 - 10.6899 | ||
| Shares Outstanding (Mil) | 14.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coya Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coya Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Coya Therapeutics Inc Frequently Asked Questions
What is Coya Therapeutics Inc(COYA)'s stock price today?
The current price of COYA is $8.40. The 52 week high of COYA is $10.69 and 52 week low is $3.21.
When is next earnings date of Coya Therapeutics Inc(COYA)?
The next earnings date of Coya Therapeutics Inc(COYA) is .
Does Coya Therapeutics Inc(COYA) pay dividends? If so, how much?
Coya Therapeutics Inc(COYA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers